Net Margin - CJ Bioscience Inc (KOSDAQ:311690) - Alpha Spread
C

CJ Bioscience Inc
KOSDAQ:311690

Watchlist Manager
CJ Bioscience Inc
KOSDAQ:311690
Watchlist
Price: 12 000 KRW 1.1% Market Closed
Market Cap: 109.4B KRW
Have any thoughts about
CJ Bioscience Inc?
Write Note

Net Margin
CJ Bioscience Inc

-432.1%
Current
-579%
Average
2.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-432.1%
=
Net Income
-21.2B
/
Revenue
4.9B

Net Margin Across Competitors

Country KR
Market Cap 109.4B KRW
Net Margin
-432%
Country US
Market Cap 34.8B USD
Net Margin
24%
Country US
Market Cap 31.3B USD
Net Margin
10%
Country AU
Market Cap 18B AUD
Net Margin
50%
Country US
Market Cap 7.6B USD
Net Margin
33%
Country JP
Market Cap 986.6B JPY
Net Margin
18%
Country US
Market Cap 6.3B USD
Net Margin
1%
Country SE
Market Cap 51.6B SEK
Net Margin
25%
Country US
Market Cap 4.6B USD
Net Margin
-9%
Country US
Market Cap 3.6B USD
Net Margin
-5%
Country US
Market Cap 2.4B EUR
Net Margin
-4%

Profitability Report

View the profitability report to see the full profitability analysis for CJ Bioscience Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-432.1%
=
Net Income
-21.2B
/
Revenue
4.9B
What is the Net Margin of CJ Bioscience Inc?

Based on CJ Bioscience Inc's most recent financial statements, the company has Net Margin of -432.1%.